Getting on Your Nerves: Is TMR with Amputation the New Standard of Care? Saturday, October 11 Sat, Oct 11 8:00-9:30 a.m. CDT
This panel explores the evolving role of Targeted Muscle Reinnervation (TMR) as a concurrent procedure during amputation surgery. Expert panelists will discuss the latest evidence supporting TMR's efficacy in preventing neuroma formation and phantom limb pain while improving prosthetic control. The session will examine surgical techniques, patient selection criteria, outcomes data, and practical considerations for implementing TMR as a standard approach in amputation care. Panelists will debate whether TMR should be considered the new standard of care and address barriers to widespread adoption.
Upon completion of this learning activity, participants should be able to:
- Evaluate the current evidence supporting TMR as a preventive measure for post-amputation neuroma and phantom limb pain.
- Describe technical considerations and surgical approaches for performing TMR concurrently with amputation.
- Identify appropriate patient selection criteria for TMR procedures.
- Assess the impact of TMR on functional outcomes and prosthetic control in amputees.
- Analyze the cost-effectiveness and resource implications of establishing TMR as a standard of care.
Accreditation: The American Society of Plastic Surgeons® (ASPS) is accredited by the Accreditation Council for Continuing Education to provide continuing medical education for physicians.
Designation: The ASPS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For hearing assistance in live sessions, please download the app "Live Transcribe" or visit Registration for additional help.